DekaBank Deutsche Girozentrale’s ALX Oncology ALXO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,000	Closed	-$508K	–	1113
2025 Q4	$508K	Hold	41,000	–	–	﹤0.01%	996
2025 Q3	$503K	Hold	41,000	–	–	﹤0.01%	987
2025 Q2	$508K	Hold	41,000	–	–	﹤0.01%	981
2025 Q1	$468K	Hold	41,000	–	–	﹤0.01%	987
2024 Q4	$443K	Hold	41,000	–	–	﹤0.01%	1025
2024 Q3	$468K	Hold	41,000	–	–	﹤0.01%	1026
2024 Q2	$468K	Hold	41,000	–	–	﹤0.01%	1018
2024 Q1	$468K	Hold	41,000	–	–	﹤0.01%	1011
2023 Q4	$627K	Hold	41,000	–	–	﹤0.01%	994
2023 Q3	$203K	Hold	41,000	–	–	﹤0.01%	1192
2023 Q2	$301K	Buy	41,000 +16,700	+69%	+$109K	﹤0.01%	1110
2023 Q1	$111K	Hold	24,300	–	–	﹤0.01%	1240
2022 Q4	$278K	Hold	24,300	–	–	﹤0.01%	1170
2022 Q3	$233K	Hold	24,300	–	–	﹤0.01%	1202
2022 Q2	$197K	Hold	24,300	–	–	﹤0.01%	1190
2022 Q1	$421K	Buy	24,300 +2,200	+10%	+$37.6K	﹤0.01%	1092
2021 Q4	$485K	Buy	22,100 +600	+3%	+$25.9K	﹤0.01%	1102
2021 Q3	$1.58M	Buy	21,500 +11,000	+105%	+$733K	﹤0.01%	785
2021 Q2	$555K	Hold	10,500	–	–	﹤0.01%	1052
2021 Q1	$717K	Hold	10,500	–	–	﹤0.01%	966
2020 Q4	$886K	Buy	+10,500	New	+$632K	﹤0.01%	898

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ALXO Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 41,000 shares — an estimated $508K sold.

DekaBank Deutsche Girozentrale first reported a position in ALXO in Q4 2020 and held it in 21 quarters. The position peaked at $1.58M in Q3 2021. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 41,000 ALX Oncology shares in Q1 2026, an estimated $508K.
DekaBank Deutsche Girozentrale first reported a position in ALX Oncology in Q4 2020 and held it in 21 quarters.
DekaBank Deutsche Girozentrale's ALX Oncology position peaked at $1.58M in Q3 2021.
69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.